ERCP for unexplained recurrent pancreatitis
Part of Digestive system clinical trials.
This study tests whether a procedure called ERCP can help find and treat the cause of recurrent pancreatitis that remains unexplained after standard tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You have had at least two separate episodes of pancreatitis that got better between attacks.
- Doctors have not found a clear cause for your pancreatitis after tests like CT or MRI.
- You must have had at least one pancreatitis attack in the past year.
- You cannot have had a previous ERCP, pancreatic surgery, or sphincter procedure.
- You must be willing to give written consent and not be pregnant or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows the natural course of recurrent acute pancreatitis and tests how well treatments work for it.
This trial tests if pirfenidone, an anti-scarring drug, can reduce the number of repeat episodes of acute pancreatitis. You may be eligible if you've had two or more pancreatitis attacks at least three months apart and are not having an active attack right now.
This trial tests if taking aspirin daily can prevent repeated attacks of acute pancreatitis. It's for people who have had at least two episodes of pancreatitis in the past year that were not caused by a medical procedure.
This study looks at how genes and medication processing in the body may relate to getting pancreatitis after an ERCP procedure. If you are having an ERCP and meet the criteria, your data and possibly samples may help researchers understand who is at higher risk.
This trial is studying how often pancreatitis happens after a common bile duct procedure called ERCP, and how a standard safety protocol might help prevent it. It aims to include people who need a therapeutic ERCP (treatment, not just diagnosis) to learn more about safe practices.
This trial studies how “inflammation” in the pancreas changes over time—going from a first or repeated attack to long-term (chronic) pancreatitis. It may help doctors understand what drives progression and identify people at higher risk for chronic disease.
Hear when a new Recurrent Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.